SPBP35G2.04c Antibody

What is SPBP35G2.04c and why is it significant for research?

SPBP35G2.04c refers to a specific protein in Schizosaccharomyces pombe (fission yeast), identified by the UniProt accession number Q9P799. This protein is studied in molecular biology research focusing on fission yeast cellular processes. The antibody against this protein enables researchers to detect, quantify, and characterize this target in experimental systems. The significance lies in its utility for investigating protein expression, localization, and function within the S. pombe model organism, which serves as an important eukaryotic model system for studying fundamental cellular processes including cell division, DNA replication, and chromosome dynamics .

What are the optimal storage conditions for the SPBP35G2.04c antibody?

The SPBP35G2.04c antibody should be stored at either -20°C or -80°C immediately upon receipt. Repeated freeze-thaw cycles should be strictly avoided as they can compromise antibody functionality through protein denaturation and aggregation. The antibody is supplied in a stabilizing solution containing 50% glycerol and 0.01M PBS (pH 7.4) with 0.03% Proclin 300 as a preservative, which helps maintain stability during storage. For short-term use (up to one week), small aliquots can be kept at 4°C, but prolonged storage at this temperature is not recommended as it may lead to decreased antibody activity .

What validated applications are available for the SPBP35G2.04c antibody?

The SPBP35G2.04c antibody has been validated for two primary applications: Enzyme-Linked Immunosorbent Assay (ELISA) and Western Blotting (WB). These applications have been tested specifically to ensure identification of the antigen with high specificity and sensitivity. When designing experiments, researchers should optimize conditions for each specific application, including appropriate dilutions, blocking reagents, and detection systems. For applications beyond ELISA and WB, additional validation would be necessary before proceeding with experimental work .

How should SPBP35G2.04c antibody be optimized for Western blot analysis?

For Western blot optimization with SPBP35G2.04c antibody, researchers should implement a systematic approach similar to methods used in SARS-CoV-2 antibody characterization studies. Begin with a titration series (1:500, 1:1000, 1:2000, 1:5000) to identify optimal antibody concentration while minimizing background. Use freshly prepared S. pombe lysates with proper controls including wild-type and SPBP35G2.04c deletion strains. The recommended blocking protocol involves 5% non-fat dry milk or 3% BSA in TBST buffer (pH 7.4) for 1 hour at room temperature. For detection, secondary antibodies conjugated with HRP or AP should be used at 1:2000-1:5000 dilution. Extended incubation times (overnight at 4°C) with primary antibody often yield cleaner results with this polyclonal antibody. Testing multiple membrane types (PVDF vs. nitrocellulose) is advisable as antibody performance can vary significantly based on membrane selection .

What are the recommended protocols for immunoprecipitation using SPBP35G2.04c antibody?

While immunoprecipitation (IP) is not explicitly listed among the validated applications for SPBP35G2.04c antibody, the following protocol can be adapted from similar polyclonal antibody approaches used in fission yeast research:

• Prepare S. pombe cell lysate in a non-denaturing buffer (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 0.5% NP-40, 1 mM EDTA with protease inhibitors)

• Pre-clear lysate with Protein A/G beads for 1 hour at 4°C

• Incubate 2-5 μg of SPBP35G2.04c antibody with 500-1000 μg of pre-cleared lysate overnight at 4°C

• Add 30-50 μl of Protein A beads (suitable for rabbit polyclonal antibodies) and incubate for 2-3 hours at 4°C

• Wash beads 4-5 times with IP buffer containing reduced detergent (0.1% NP-40)

• Elute proteins by boiling in SDS-PAGE sample buffer

• Analyze by Western blotting

Cross-validation with other techniques is strongly recommended when establishing new IP protocols, particularly since this application has not been explicitly validated by the manufacturer .

How can researchers validate specificity when using SPBP35G2.04c antibody?

To validate the specificity of SPBP35G2.04c antibody, multiple complementary approaches should be employed:

• Genetic controls: Compare immunostaining patterns between wild-type S. pombe and SPBP35G2.04c deletion or knockdown strains

• Peptide competition assay: Pre-incubate the antibody with excess recombinant SPBP35G2.04c protein (the immunogen) before using in experiments; specific signals should be abolished

• Molecular weight verification: Confirm that the detected band appears at the expected molecular weight for SPBP35G2.04c

• Alternative antibodies: When available, compare results with other antibodies targeting different epitopes of the same protein

• Mass spectrometry: Perform IP followed by mass spectrometry to confirm the identity of the pulled-down protein

These validation steps are particularly important for polyclonal antibodies like the SPBP35G2.04c antibody, as batch-to-batch variation can occur .

What are the considerations for using SPBP35G2.04c antibody in chromatin immunoprecipitation (ChIP) experiments?

While ChIP is not listed among the validated applications for SPBP35G2.04c antibody, researchers interested in pursuing this application should consider the following approach based on methodologies used with other polyclonal antibodies in S. pombe research:

• Antibody screening: First validate antibody specificity by Western blot against nuclear extracts from S. pombe

• Crosslinking optimization: Test different formaldehyde concentrations (0.5-1.5%) and crosslinking times (5-20 minutes)

• Sonication parameters: Optimize sonication conditions to generate DNA fragments of 200-500 bp

• Antibody amount: Titrate antibody concentration (2-10 μg per reaction) to determine optimal signal-to-noise ratio

• Controls: Include input sample, no-antibody control, and ideally a SPBP35G2.04c deletion strain as negative control

• Validation: Confirm enrichment of expected target regions by qPCR before proceeding to genome-wide analysis

Since the SPBP35G2.04c antibody is raised against the full recombinant protein, it may recognize native protein conformations required for successful ChIP, but this must be empirically determined. Additional validation strategies such as peptide competition assays should be implemented to confirm specificity in the ChIP context .

What strategies can be employed to overcome potential cross-reactivity issues with SPBP35G2.04c antibody?

Polyclonal antibodies like SPBP35G2.04c may exhibit cross-reactivity with structurally similar proteins. To address this challenge, consider implementing the following strategies:

• Pre-adsorption: Incubate the antibody with lysates from organisms lacking the target protein to remove antibodies that recognize conserved epitopes

• Affinity purification: Further purify the commercial antibody against the specific antigen using immobilized recombinant SPBP35G2.04c

• Western blot analysis: Run samples from related species alongside S. pombe to identify potential cross-reactive bands

• Blocking optimization: Test different blocking reagents (BSA, non-fat milk, commercial blockers) to reduce non-specific binding

• Detergent adjustment: Optimize detergent type and concentration in washing buffers to reduce background while maintaining specific signal

• Sequential probing: In co-localization studies, use directly conjugated antibodies or sequential rather than simultaneous probing

These approaches can significantly improve signal specificity, particularly in complex samples or when studying proteins with high homology across species .

How can SPBP35G2.04c antibody be integrated into multiplexed immunoassays?

For researchers developing multiplexed detection systems that include SPBP35G2.04c antibody, the following methodological considerations should be addressed:

• Conjugation chemistry: The antibody can be directly labeled using NHS-ester fluorophores, biotin, or enzymatic labels, though this may affect binding affinity

• Compatibility testing: Evaluate potential cross-reactivity with other antibodies in the multiplex panel through systematic pairwise testing

• Sequential detection: Consider sequential rather than simultaneous detection to minimize antibody cross-interference

• Signal amplification: For low-abundance targets, implement tyramide signal amplification or similar approaches

• Spectral overlap: When using fluorescent detection, carefully select fluorophores to minimize spectral overlap

• Validation: Validate multiplexed results against single-plex controls to ensure sensitivity and specificity are maintained

Multiplexed approaches require extensive optimization but can dramatically increase data output from limited samples when properly implemented .

What are the common challenges in SPBP35G2.04c detection and how can they be addressed?

When working with SPBP35G2.04c antibody, researchers commonly encounter these challenges:

Systematic optimization focusing on these parameters can significantly improve experimental outcomes in SPBP35G2.04c detection assays .

How should researchers normalize and quantify Western blot data when using SPBP35G2.04c antibody?

For accurate quantification of SPBP35G2.04c in Western blot analyses, implement the following best practices:

• Loading control selection: Use housekeeping proteins appropriate for S. pombe (e.g., α-tubulin, GAPDH) that do not vary under your experimental conditions

• Linear dynamic range determination: Perform a dilution series of your sample to establish the linear range of detection for both SPBP35G2.04c and loading control

• Technical replicates: Include at least three technical replicates per biological sample

• Imaging optimization: Avoid oversaturation when capturing images; use systems with a wide dynamic range

• Analysis software: Utilize specialized software (ImageJ, Image Lab, etc.) for densitometric analysis

• Normalization approach: Calculate relative expression using the formula:
  $\text{Normalized expression} = \frac{\text{SPBP35G2.04c band intensity}}{\text{Loading control band intensity}}$

• Statistical analysis: Apply appropriate statistical tests to determine significance between experimental conditions

Consistent application of these quantification principles will improve reproducibility and reliability of SPBP35G2.04c expression analyses .

What experimental controls are essential when working with SPBP35G2.04c antibody?

When designing experiments with SPBP35G2.04c antibody, the following controls are essential:

• Positive control: Wild-type S. pombe lysate known to express SPBP35G2.04c

• Negative control: Lysate from SPBP35G2.04c deletion or knockdown strains

• Loading control: Consistent protein loading verified by housekeeping protein detection

• Antibody controls:

  • Primary antibody omission control

  • Secondary antibody only control

  • Isotype control (rabbit IgG at equivalent concentration)

• Peptide competition control: Pre-incubation of antibody with excess immunizing antigen

• Processing controls: Samples processed identically except for the experimental variable

• Technical replicates: Multiple technical replicates to establish reproducibility

Implementation of these controls will help distinguish true signals from artifacts and enable more confident data interpretation. For advanced applications such as immunofluorescence or ChIP, additional controls specific to those techniques should be included .

How can machine learning approaches be combined with SPBP35G2.04c antibody-based assays?

Integrating machine learning with SPBP35G2.04c antibody-based assays can enhance data analysis and experimental planning:

• Epitope prediction: Use computational algorithms to predict potential binding sites of the antibody based on protein structure, improving experimental design

• Automated image analysis: Apply deep learning for high-throughput analysis of immunofluorescence or immunohistochemistry data

• Signal pattern recognition: Train models to recognize specific staining patterns associated with different cellular conditions or protein interactions

• Experimental design optimization: Implement active learning algorithms to iteratively improve experimental conditions based on previous results

• Cross-reactivity prediction: Predict potential cross-reactive proteins based on sequence homology and epitope structure

• Multiplexed data integration: Use machine learning to integrate data from antibody-based assays with other -omics datasets

When implementing these approaches, researchers should establish proper validation metrics and maintain sufficient non-machine-learning controls to verify computational predictions. The machine learning strategies used for antibody-antigen binding prediction discussed in the literature provide a framework for developing S. pombe-specific models .

What considerations are important when designing super-resolution microscopy experiments with SPBP35G2.04c antibody?

When adapting SPBP35G2.04c antibody for super-resolution microscopy applications, researchers should consider the following methodological adjustments:

• Fixation optimization: Test multiple fixation protocols (paraformaldehyde, methanol, glutaraldehyde) to preserve epitope accessibility while maintaining cellular ultrastructure

• Antibody concentration: Typically lower concentrations are needed compared to conventional immunofluorescence to reduce background

• Secondary antibody selection: Use highly cross-adsorbed secondary antibodies with bright, photostable fluorophores designed for super-resolution

• Mounting media: Select media specifically formulated for super-resolution techniques with appropriate refractive index and anti-fade properties

• Blocking enhancement: Implement more stringent blocking protocols using combination blockers (BSA + serum + casein)

• Validation controls: Include parallel conventional microscopy samples to confirm staining patterns

• Multi-color considerations: When combining with other antibodies, carefully assess chromatic aberration and registration issues

Each super-resolution technique (STED, STORM, PALM) may require specific optimization of these parameters. Since this antibody has not been explicitly validated for microscopy applications, extensive preliminary testing is essential .

How can SPBP35G2.04c antibody be incorporated into single-cell analysis workflows?

To integrate SPBP35G2.04c antibody into single-cell analysis platforms, consider these methodological approaches:

• Antibody conjugation: Directly conjugate the antibody to fluorophores, metal isotopes (for CyTOF), or barcodes compatible with single-cell platforms

• Cell preparation: Optimize gentle cell wall digestion protocols for S. pombe to maintain epitope integrity while enabling single-cell suspension

• Fixation and permeabilization: Test graded methanol or saponin-based permeabilization to enable antibody access while preserving cell viability

• Multiplexing strategy: Design antibody panels with careful consideration of spectrum overlap and potential cross-reactivity

• Sorting validation: Validate antibody performance in flow cytometry before proceeding to complex single-cell sorting experiments

• Data integration: Develop computational pipelines to integrate antibody-based protein detection with transcriptomic or other single-cell data

• Spike-in controls: Include control samples with known SPBP35G2.04c expression levels to enable cross-experiment normalization

The rapid development of single-cell multimodal assays offers exciting opportunities to correlate SPBP35G2.04c protein expression with other cellular parameters at unprecedented resolution .